Noha Elnagar, PA
Physician Assistant · Toledo, OHNPI 1215324132
Payments from drug & device makers
Across 168 payments — averaging $55.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$4K
- Medtronic$2K
- Novo Nordisk$605
- Corcept Therapeutics$427
- Dexcom, Inc.$395
- Lilly USA, LLC$368
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$3,37536%
- Travel & lodging$1,71318%
- Food & beverage$4,24545%
- Education$110%
- Other$501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 17 | $3,526 |
| Medtronic | 27 | $2,352 |
| Novo Nordisk | 27 | $605 |
| Corcept Therapeutics | 8 | $427 |
| Dexcom, Inc. | 15 | $395 |
| Lilly USA, LLC | 21 | $368 |
| Abbott | 17 | $287 |
| AstraZeneca | 6 | $233 |
| Bayer | 2 | $141 |
| Insulet Corporation | 2 | $131 |
| Inari Medical, Inc. | 1 | $117 |
| Vertex | 1 | $108 |
| Boehringer Ingelheim | 4 | $92 |
| Si-bone, Inc. | 1 | $89 |
| Integra Lifesciences Corporation | 1 | $88 |
| Johnson & Johnson(2 entities) | 2 | $70 |
| AbbVie | 1 | $66 |
| Lifenet Health | 1 | $56 |
| Radius Health, Inc. | 2 | $38 |
| Gilead | 2 | $28 |
| BETA Bionics, Inc. | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Mannkind Corporation | 1 | $18 |
| Sequel Med Tech, LLC | 1 | $18 |
| Amgen | 1 | $17 |
| Cequr Corporation | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$3,478
- MINIMED 780G$1,824
- Korlym$345
- DEXCOM G6 TRANSMITTER$232
- Ozempic$125
- Wegovy$125
- Kerendia$120
- FLOWTRIEVER CATHETER, S$117
- CT THROMBECTOMY SYSTEM KIT$117
- Omnipod$111
- JOURNAVX$108
- FARXIGA$101
How this compares
$9,394 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 335 | $437,353 |
| JardianceEmpagliflozin | 278 | $246,667 |
| MounjaroTirzepatide | 160 | $239,236 |
| TrulicityDulaglutide | 202 | $232,550 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 104 | $163,122 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 78 | $90,385 |
| FarxigaDapagliflozin Propanediol | 95 | $85,970 |
| Tresiba Flextouch U-100Insulin Degludec | 136 | $76,176 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 62 | $60,053 |
| Tresiba Flextouch U-200Insulin Degludec | 54 | $59,197 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 53 | $39,308 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $31,951 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 173 | $22,564 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 42 | $21,174 |
| Humalog Kwikpen U-100Insulin Lispro | 69 | $20,943 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $368 | $480,109427 claims |
| Novo NordiskOzempic, Novolog | $605 | $442,961360 claims |
| Boehringer IngelheimJardiance | $92 | $246,667278 claims |
| AstraZenecaFarxiga | $233 | $85,97095 claims |
| MerckJanumet | $14 | $14,33511 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $52351 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Toledo
- Alison FleigToledo$48K
- Ashley SheskeyToledo$20K
- Jessica PalickiToledo$19K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.